我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
3
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
1
33.3%
尚未招募
2
66.7%
暂无批准数据
- University of Nottingham initiates groundbreaking TrueBlue trial using AI and virtual avatar technology to detect early-stage postnatal depression, offering a modern alternative to traditional clinical scales. - The 12-week study features an innovative virtual human avatar named Kiera, guiding participants through tasks to monitor mood patterns and enable earlier detection of mood disorders. - The trial offers flexible participation options, allowing subjects to engage either in-person at the Institute of Mental Health or completely online, prioritizing convenience and accessibility.
